İçeriğe geç
akaturk Akademik ölçüm

Makale detayı · 2017

The neutrophil-to-lymphocyte ratio as a diagnostic marker for malignant thyroid diseases

Turkish Journal of Biochemistry

YÖKSİS OpenAlex Açık erişim · gold SJR Q3 JCR Q4 TR Index Atıf 6 Yüzdelik 59.5% FWCI 0.32
Yıl
2017
ISSN
1303-829X
Tür
article

Veri kaynağı ayrımı

  • YÖKSİS YÖKSİS makale kaydı
  • OpenAlex OpenAlex zenginleştirmesi (özet, atıf, konular)

Özet

İngilizce (OpenAlex)

Abstract Background The neutrophil-lymphocyte ratio (NLR) is a good marker of malignant diseases. The aim of this study was to investigate NLR as a diagnostic marker of thyroid cancer in patients with malignant thyroid diseases compared to those with benign thyroid diseases. Methods Two hundred and fifty three patients were divided into two groups: benign and malignant thyroid disease patients. Malignant thyroid disease group was not sub-grouped further into differentiated and undifferentiated. The preoperative complete blood count and biochemical parameters, including NLR, were evaluated. Results The mean neutrophil count was found to be significantly higher, whereas the mean lymphocyte count was found to be significantly lower in the malignant group which includes 40 of the patients. As a result, NLR was significantly higher in the malignant group than in the benign group (p<0.001). Conclusion This is the first study to show the value of NLR as a marker for malignant thyroid diseases including all subtypes.

Konular

  • Inflammatory Biomarkers in Disease Prognosis
  • Thyroid Cancer Diagnosis and Treatment
  • Biomarkers in Disease Mechanisms

Birincil konu Inflammatory Biomarkers in Disease Prognosis

Yazarlar

  1. SEZGİN ZEREN
  2. İsa Özbay
  3. ZÜLFÜ BAYHAN
  4. FATMA EMEL KOÇAK
  5. BERCİS İMGE UÇAR GÖKER
  6. CÜNEYT KAHRAMAN
  7. ŞÜKRÜ AYDIN DÜZGÜN
  8. CENGİZ KOÇAK KÜTAHYA SAĞLIK BİLİMLERİ ÜNİVERSİTESİ